Figure 2.

Cdc28 inhibition causes a decrease of Cdc20 levels during a checkpoint arrest. (A–D) CDC28 PDS1-MYC18 (yAC359) and cdc28-as1 PDS1-MYC18 (yAC779) cells were synchronized in G1 phase with α-factor and then released in YEPD supplemented with nocodazole. After 3 h in nocodazole, the indicated concentrations of 1-NMPP1 or DMSO were added together with 20 µg/ml of α-factor. Samples were taken at the indicated times after the addition of 1-NMPP1 or DMSO for Western blotting. (E, top) cdc28-as1 MAD2-3GFP NUF2-mCherry (yAC2182) cells were treated similarly to A–D: after 2.5 h in nocodazole (noco), cells were kept two additional hours in the presence of nocodazole supplemented with DMSO, 500 nM, or 5 µM 1-NMPP1 (120 min). One fraction of cells was instead released from nocodazole (Release). Colocalization of Mad2 with Nuf2 was scored at 120 min (see also Materials and methods); error bars refer to standard errors from three independent experiments. In each experiment, 50 cells were analyzed for each condition. (E, bottom) Examples of localized and nonlocalized Mad2.

or Create an Account

Close Modal
Close Modal